King Pharmaceuticals KG Proceeds from maturities, paydowns and calls of fixed maturities

Proceeds from maturities, paydowns and calls of fixed maturities at other companies

Bank First CorporationBFC

$17.62M-93.1%

Columbia Financial, Inc.CLBK

$1.25M—

ESN

Essent GroupESNT

$212.99M+12.8%

MetroCity BanksharesMCBS

$909K-54.3%

10x Genomics, Inc.TXG

$25M—

CNB FinancialCCNE

$27.88M+42.2%

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-71.3%

Enterprise value$184.93M-52.3%

P/E1.2×—

P/S1.6×-27.7×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept kg:ProceedsFromMaturitiesPrepaymentsAndCallsOfDebtSecuritiesInvestingActivities.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's proceeds from maturities, paydowns and calls of fixed maturities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's proceeds from maturities, paydowns and calls of fixed maturities?: King Pharmaceuticals (KG) reported proceeds from maturities, paydowns and calls of fixed maturities of $44.27M in Q1 2026.
What does proceeds from maturities, paydowns and calls of fixed maturities mean?: Cash inflows resulting from the scheduled maturity, early prepayment, or redemption of fixed-income investment securities. This metric reflects the liquidity generated from the company's investment portfolio as assets reach their end-of-life or are called by issuers. It is used to evaluate the reinvestment strategy and the cash-generating capacity of the investment book.